{"id":"W2954187556","doi":"10.1200/jco.2019.37.15_suppl.8005","title":"Efficacy and safety of the randomized, open-label, non-inferiority, phase 3 study of subcutaneous (SC) versus intravenous (IV) daratumumab (DARA) administration in patients (pts) with relapsed or refractory multiple myeloma (RRMM): COLUMBA.","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Population; Internal medicine; Adverse effect; Refractory (planetary science); Phases of clinical research; Daratumumab; Gastroenterology; Surgery; Clinical trial; Multiple myeloma; Lenalidomide","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003722984,0.001867643,0.002253193,0.0005754577,0.0007100148,0.001571167,0.001214006,0.002208509,0.009477719],"category_scores_gemma":[0.002703267,0.001008611,0.002183071,0.0005813395,0.001855857,0.00135773,0.0005299682,0.00489406,0.001609539],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001777753,"about_ca_system_score_gemma":0.002649846,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001301342,"about_ca_topic_score_gemma":0.003020277,"domain_scores_codex":[0.9985731,0.0009046524,0.00004872293,0.0001967384,0.0001023024,0.0001746147],"domain_scores_gemma":[0.9976814,0.00059882,0.0006429341,0.0001888801,0.0001259036,0.0007620155],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9710395,0.01492433,0.0007073049,0.000176573,0.0004214552,0.00003466566,0.00007249675,0.0002701952,0.003415965,0.00007650307,0.000567617,0.008293415],"study_design_scores_gemma":[0.9120296,0.08451614,0.001846284,0.00001364878,0.0001863448,0.00003822853,0.00001610517,0.0004345015,0.0003555538,0.00009778295,0.0004545974,0.00001129316],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9897195,0.001563519,0.0007571724,0.0006305301,0.0002746778,0.004384967,0.0009275673,0.0001134938,0.001628592],"genre_scores_gemma":[0.9891841,0.0007070786,0.001237844,0.0009288341,0.0002774798,0.004409299,0.0008543159,0.0000319621,0.002369126],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.009477719,"threshold_uncertainty_score":0.03170609,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08786617734048409,"score_gpt":0.4492467691867956,"score_spread":0.3613805918463115,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}